Characterization of the interaction between fenamates and hippocampal neuron GABAA receptors

Document Type

Article

Publication Title

Neurochemistry International

ISSN

0197-0186

Volume

51

Issue

2021-06-07

DOI

10.1016/j.neuint.2007.04.017

First Page

440

Last Page

446

Publication Date

11-1-2007

Abstract

Fenamate NSAIDs have several central effects, including anti-epileptic and neuroprotective actions. The underlying mechanism(s) of these actions are not presently understood. In this study, the effects of five members of the fenamate NSAID group were investigated on native ligand-gated ion channels expressed in cultured rat hippocampal neurons. All fenamates tested (1-100 μM) dose-dependently potentiated GABA-evoked currents; mefenamic acid (MFA) was the most potent and efficacious and was found to shift the GABA dose-response curve to the left without effect on the maximum amplitude or the GABA Hill Slope. The modulation of GABA receptors by MFA was not reduced in the presence of the benzodiazepine antagonist, flumazenil (10 μM) and was moderately voltage-dependent. MFA at concentrations ≥10 μM evoked dose-dependent currents in the absence of GABA. These currents were potentiated by diazepam (1 μM) and blocked by bicuculline (10 μM). The MFA (50 μM) current-voltage relationship and reversal potential were similar to that evoked by GABA. MFA (1-100 μM) had no effects on sub-maximal glycine, glutamate or NMDA evoked currents. These data show that fenamate NSAIDs are a highly effective class of GABA receptor modulator and activators. © 2007 Elsevier Ltd. All rights reserved. A

Link to Full Text

Share

COinS